John R. Martin's most recent trade in Deciphera Pharmaceuticals Inc was a trade of 30,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 21, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Deciphera Pharmaceuticals Inc | John R. Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | John R. Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | John R. Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) |